Piperidine derivatives as NMDA receptor antagonists
US7435744B2 · kind B2 · utility
4Cited by
9References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2004 |
| Grant date | Oct 14, 2008 |
| Priority date | — |
| Expiry date | Aug 23, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of formula (I):wherein: V and U are hydrogen, halogen, C1-C4 alkylamino, or together form a group that contains one or more heteroatoms, and that taken together with one or more:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.